Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (94 ms)

Resources that use this resource

No resources found

Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm	RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm	RxNorm

Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1196.495",
  "meta" : {
    "versionId" : "16",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "Elimu Informatics Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2021-09-09"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.495",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1196.495"
    }
  ],
  "version" : "20210909",
  "name" : "ICSLABALAMAPreparations",
  "title" : "ICS LABA LAMA Preparations",
  "status" : "active",
  "experimental" : false,
  "date" : "2021-09-09T01:01:05-04:00",
  "publisher" : "NHLBI Implementation Science and Health Care Innovation Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This valueset contains oral inhaled corticosteroid preparations in combination with a long-acting beta agonist and a long-acting muscarinic antagonist that may be used for maintenance controller therapy in adult asthmatics.  As of Sept 2020, the oral inhalant combination of fluticasone furoate + umeclidinium + vilanterol is indicated for the maintenance treatment of asthma in patients aged 18 years and older.),(Data Element Scope: FHIR \nMedicationStatement.medicationCodeableConcept, MedicationRequest.medicationCodeableConcept),(Inclusion Criteria: Includes fluticasone/umeclidinium/vilanterol oral inhalation preparations),(Exclusion Criteria: none)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1945039",
            "display" : "14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"
          },
          {
            "code" : "1945044",
            "display" : "14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"
          },
          {
            "code" : "1945047",
            "display" : "30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"
          },
          {
            "code" : "1945048",
            "display" : "30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:5bbd040a-0c11-4f29-aed2-f2dc0e68552d",
    "timestamp" : "2024-12-10T07:37:44-05:00",
    "total" : 4,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1945039",
        "display" : "14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1945044",
        "display" : "14 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1945047",
        "display" : "30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1945048",
        "display" : "30 ACTUAT fluticasone furoate 0.1 MG/ACTUAT / umeclidinium 0.0625 MG/ACTUAT / vilanterol 0.025 MG/ACTUAT Dry Powder Inhaler [Trelegy]"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.